Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 11:41 am Purchase |
2024-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM |
Frazier Life Sciences Public Fund, L.P. | 1,041,667 11.000% |
1,041,667 (New Position) |
Filing History |
| 2024-01-25 1:24 pm Purchase |
2024-01-23 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Frazier Life Sciences Public Fund, L.P. | 4,142,855 6.200% |
4,142,855 (New Position) |
Filing History |
| 2023-12-14 1:33 pm Purchase |
2023-12-12 | 13D | KalVista Pharmaceuticals, Inc. KALV |
Frazier Life Sciences Public Fund, L.P. | 3,582,294 10.400% |
343,435 (+10.60%) |
Filing History |
| 2023-10-05 12:23 pm Sale |
2023-10-03 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Frazier Life Sciences Public Fund, L.P. | 0 0.000% |
-3,708,838 (Position Closed) |
Filing History |
| 2023-09-27 10:26 am Purchase |
2023-09-25 | 13D | HilleVax, Inc. HLVX |
Frazier Life Sciences Public Fund, L.P. | 9,806,472 20.200% |
25,000 (+0.26%) |
Filing History |
| 2023-05-26 5:29 pm Purchase |
2023-05-24 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences Public Fund, L.P. | 10,125,788 18.500% |
1,697,683 (+20.14%) |
Filing History |
| 2023-05-05 4:13 pm Purchase |
2023-04-13 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences Public Fund, L.P. | 8,428,105 19.300% |
8,428,105 (New Position) |
Filing History |
| 2023-05-05 4:12 pm Purchase |
2023-04-28 | 13D | HilleVax, Inc. HLVX |
Frazier Life Sciences Public Fund, L.P. | 9,781,472 25.000% |
144,240 (+1.50%) |
Filing History |
| 2023-04-17 5:29 pm Sale |
2023-04-13 | 13G | Allakos Inc. ALLK |
Frazier Life Sciences Public Fund, L.P. | 392,269 0.500% |
-4,399,731 (-91.81%) |
Filing History |
| 2023-02-14 12:19 pm Sale |
2022-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Frazier Life Sciences Public Fund, L.P. | 2,109,154 3.000% |
-78,850 (-3.60%) |
Filing History |
| 2023-02-14 12:19 pm Sale |
2022-12-31 | 13G | TRICIDA INC TCDAQ |
Frazier Life Sciences Public Fund, L.P. | 1,500,000 2.500% |
-2,082,093 (-58.13%) |
Filing History |
| 2023-02-14 12:12 pm Purchase |
2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Frazier Life Sciences Public Fund, L.P. | 3,708,838 5.400% |
936,776 (+33.79%) |
Filing History |
| 2023-02-14 12:09 pm Purchase |
2022-12-31 | 13G | Autolus Therapeutics plc AUTL |
Frazier Life Sciences Public Fund, L.P. | 3,746,857 2.200% |
16,200 (+0.43%) |
Filing History |
| 2023-02-14 12:08 pm Purchase |
2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
Frazier Life Sciences Public Fund, L.P. | 5,223,655 6.300% |
495,104 (+10.47%) |
Filing History |
| 2023-02-14 12:05 pm Purchase |
2022-12-31 | 13G | Chinook Therapeutics, Inc. KDNY |
Frazier Life Sciences Public Fund, L.P. | 4,052,510 6.300% |
1,282,484 (+46.30%) |
Filing History |
| 2023-02-14 12:03 pm Sale |
2022-12-31 | 13G | Gracell Biotechnologies Inc. GRCL |
Frazier Life Sciences Public Fund, L.P. | 0 0.000% |
-17,104,865 (Position Closed) |
Filing History |
| 2023-02-14 11:58 am Purchase |
2022-12-31 | 13G | Allakos Inc. ALLK |
Frazier Life Sciences Public Fund, L.P. | 4,792,000 5.600% |
1,892,000 (+65.24%) |
Filing History |
| 2023-01-23 12:17 pm Purchase |
2023-01-13 | 13G | Theseus Pharmaceuticals, Inc. THRX |
Frazier Life Sciences Public Fund, L.P. | 2,248,194 5.800% |
2,248,194 (New Position) |
Filing History |
| 2022-12-30 2:15 pm Purchase |
2022-12-28 | 13D | KalVista Pharmaceuticals, Inc. KALV |
Frazier Life Sciences Public Fund, L.P. | 3,238,859 9.500% |
1,666,667 (+106.01%) |
Filing History |
| 2022-10-07 2:51 pm Purchase |
2022-10-05 | 13G | Trevi Therapeutics, Inc. TRVI |
Frazier Life Sciences Public Fund, L.P. | 6,663,590 11.400% |
2,847,131 (+74.60%) |
Filing History |